At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...
The optimal strategy for treating newly diagnosed high-risk prostate cancer remains unclear. More specifically, do these patients benefit more from radical prostatectomy or a radiotherapy-based ...
According to data from two phase III trials presented at this year's American Society of Clinical Oncology Genitourinary Cancers Symposium, patients with high-risk prostate cancer had a significantly ...
There will be approximately 299,010 new cases of prostate cancer diagnosed in 2024, according to the American Cancer Society. Treatments vary, including chemotherapy, hormone therapy, ablative therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results